Fujiyama S - Search Results

1

Impaired hepatic granuloma formation in mice deficient in C-C chemokine receptor 2.

Jinnouchi K, Terasaki Y, Fujiyama S, Tomita K, Kuziel WA, Maeda N, Takahashi K, Takeya M. Jinnouchi K, et al. Among authors: fujiyama s. J Pathol. 2003 Jul;200(3):406-16. doi: 10.1002/path.1362. J Pathol. 2003. PMID: 12845637

2

The role of macrophage colony-stimulating factor in the differentiation and proliferation of Kupffer cells in the liver of protein-deprived mice.

Honda Y, Takahashi K, Naito M, Fujiyama S. Honda Y, et al. Among authors: fujiyama s. Lab Invest. 1995 Jun;72(6):696-706. Lab Invest. 1995. PMID: 7783428

3

Effective interferon therapy for chronic hepatitis C patients with low viral loads.

Fujiyama S, Chikazawa H, Honda Y, Tomita K. Fujiyama S, et al. Hepatogastroenterology. 2003 May-Jun;50(51):817-20. Hepatogastroenterology. 2003. PMID: 12828092

4

Expression of arginase II and related enzymes in the rat small intestine and kidney.

Ozaki M, Gotoh T, Nagasaki A, Miyanaka K, Takeya M, Fujiyama S, Tomita K, Mori M. Ozaki M, et al. Among authors: fujiyama s. J Biochem. 1999 Mar;125(3):586-93. doi: 10.1093/oxfordjournals.jbchem.a022324. J Biochem. 1999. PMID: 10050048 Free article.

5

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.

Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Fujiyama S, et al. Oncology. 2002;62 Suppl 1:57-63. doi: 10.1159/000048277. Oncology. 2002. PMID: 11868787 Review.

6

[Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)].

Tanaka M, Fujiyama S, Tanaka M, Itoh K, Matsushita K, Hara M, Kuwahara K, Yasumoto N, Nishimura Y, Yoshimura N, Tomita K. Tanaka M, et al. Among authors: fujiyama s. Nihon Jinzo Gakkai Shi. 2003;45(2):91-7. Nihon Jinzo Gakkai Shi. 2003. PMID: 12703404 Japanese.

7

Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization.

Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Maeda S, et al. Among authors: fujiyama s. Hepatol Res. 2002 Jul;23(3):202-210. doi: 10.1016/s1386-6346(01)00174-7. Hepatol Res. 2002. PMID: 12076716

8

Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.

Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K. Maeda S, et al. Among authors: fujiyama s. Hepatogastroenterology. 2003 May-Jun;50(51):809-13. Hepatogastroenterology. 2003. PMID: 12828090

9

Enzyme-linked immunosorbent assay of carbamoylphosphate synthetase I: plasma enzyme in rat experimental hepatitis and its clearance.

Ozaki M, Terada K, Kanazawa M, Fujiyama S, Tomita K, Mori M. Ozaki M, et al. Among authors: fujiyama s. Enzyme Protein. 1994-1995;48(4):213-21. doi: 10.1159/000474991. Enzyme Protein. 1994. PMID: 8821709

10

Evaluation of the timing of the booster injection after a primary vaccination against hepatitis A.

Fujiyama S, Odoh K, Tanaka M, Kuramoto I, Tomita K. Fujiyama S, et al. J Gastroenterol Hepatol. 1997 Feb;12(2):172-5. doi: 10.1111/j.1440-1746.1997.tb00402.x. J Gastroenterol Hepatol. 1997. PMID: 9083920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters